Surfing the MASH Tsunami
Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL
Surfing the MASH Tsunami
"Beond the Biopsy" How NASH Therapy Will Improve When Non-Invasive Tests Become The Standard - Ep 26
The Surfers discuss the Global Liver Institute's campaign to educate and motivate key stakeholder groups on the value of non-invasive liver testing.
Donna Cryer, President and CEO of the Global Liver Institute, discusses GLI's "Beyond the Biopsy" campaign while Stephen Harrison, Louise Campbell, and Roger Green join in with education, messages, and ideas. The "Beyond the Biopsy" campaign focuses on the importance of gaining acceptance for non-invasive liver testing. Stephen discusses why validation matters and why "H" is a magic letter. Roger discusses the history of statins and the importance of what appears on blood testing results. Louise discusses simple things that healthcare can do to diagnose and treat liver disease before it becomes deadly. An eye-opening episode!